The Amanta Healthcare IPO began on 01-September-2025. It will close on 03-September-2025. The Total IPO Size is 126 Crores. The company set its IPO price at 120-126 Rs Per Share.
There are three basic categories in Amanta Healthcare IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors 3) Retail.
Amanta Healthcare are pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products – parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”) and Injection Strech Blow Moulding (“ISBM”) technology
They manufacture fluid therapy – (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc.
They manufacture diverse generics product portfolio of over 45 products and market them under their brands in the Indian market through
a network of over 316 distributors and stockists.
They exported branded products to 19 countries and sell their products in various countries including the Africa, Latin America, UK and the Rest of the world.
Amanta Healthcare IPO Promoters
Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited are the promoters of the company.
Amanta Healthcare IPO Date, Details & Price Band
The Amanta Healthcare IPO Price Band, IPO Dates, Market lot and other details are mentioned in the table below.
IPO Opening Dates | 01-September-2025 |
IPO Closing Dates | 03-September-2025 |
Price | 120-126 Rs |
Fresh Issue | 126.00 Crores |
Offer for Sale | NIL |
Total IPO size | 126.00 Crores |
Face Value | 10 INR Per Share |
Issue Type | Book Building |
QIB Allocation | 50% |
HNI Allocation | 15% |
Retail Allocation | 35% |
Listing On | NSE, BSE |
Amanta Healthcare IPO Market Lot
The Amanta Healthcare IPO minimum market lot is 119 shares with a 14,994 ₹ Amount per application.
Lot | No of Shares | Amount | |
Retail Minimum | 1 | 119 | 14,994 ₹ |
Retail Maximum | 13 | 1,547 | 1,94,922 ₹ |
S-HNI Minimum | 14 | 1,666 | 2,09,916 ₹ |
S-HNI Maximum | 66 | 7,854 | 9,89,604 ₹ |
B-HNI Minimum | 67 | 7,973 | 10,04,598 ₹ |
Restated Consolidated Financial Information (Amt. in Crore)
Total Assets | Total Revenue | Profit After Tax | |
31-Mar-25 | 381.76 | 276.09 | 10.50 |
31-Mar-24 | 352.12 | 281.61 | 3.63 |
31-Mar-23 | 374.06 | 262.70 | -2.11 |
Amanta Healthcare IPO GMP & Grey Market Premium
Amanta Healthcare IPO GMP Grey market premium has started today. Check the Latest Amanta Healthcare IPO GMP, Kostak Rates, and Subject to Sauda Price here.
Amanta Healthcare IPO Prospectus
Amanta Healthcare IPO Prospectus is Available on the NSE/BSE and SEBI website as well as on our Portal. Please click here to download the Amanta Healthcare IPO Prospectus.
DRHP | Download |
RHP | Download |
Anchor Investor List | Download |
Amanta Healthcare IPO Allotment Date & Details
Allotment Date | 04-Sep-2025 |
Initiation of refunds | 08-Sep-2025 |
Transfer of shares to Demat accounts | 08-Sep-2025 |
Listing Date | 09-Sep-2025 |
Check Allotment Status | Click here |
Registrar of Amanta Healthcare
MUFG Intime India Private Limited
C-101, 1st Floor, 247 Park, L.B.S. Marg
Vikhroli (West), Mumbai 400 083, Maharashtra
Telephone: +91 8108114949
E-mail: [email protected]
Investor grievance e-mail: [email protected]
Website: www.linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI registration number: INR000004058
Amanta Healthcare Contact Details
Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: [email protected]
Website: https://www.amanta.co.in/
Amanta Healthcare IPO Lead Managers
Beeline Capital Advisors Private Limited
B 1311-1314 Thirteenth Floor Shilp Corporate Park, Rajpath Rangoli Road
Thaltej, Ahmedabad 380054, Gujarat
Telephone: +91 79 4918 5784
E-mail: [email protected]
Investor grievance e-mail: [email protected]
Website: www.beelinemb.com
Contact person: Nikhil Shah
SEBI Registration No.: INM000012917